Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Kronos Bio is a biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting deregulated transcription factors involved in cancer and autoimmune diseases. Using proprietary systems biology and drug discovery platforms, it aims to modulate critical nodes within transcriptional regulatory networks. Its core approach involves precision medicine strategies to develop targeted treatments for high unmet medical needs in oncology and autoimmune disorders.
This description was generated via AI from an annual report. Updated about 1 year ago.